Somewhat Positive Press Coverage Somewhat Unlikely to Affect Orthopediatrics (KIDS) Stock Price

News articles about Orthopediatrics (NASDAQ:KIDS) have been trending somewhat positive recently, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Orthopediatrics earned a media sentiment score of 0.04 on Accern’s scale. Accern also assigned media stories about the company an impact score of 45.1169332232962 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Shares of Orthopediatrics (NASDAQ:KIDS) traded up $0.32 during mid-day trading on Friday, hitting $18.82. 25,200 shares of the stock were exchanged, compared to its average volume of 75,447. Orthopediatrics has a 12 month low of $17.03 and a 12 month high of $23.00. The company has a current ratio of 2.78, a quick ratio of 1.00 and a debt-to-equity ratio of -0.38.

A number of equities analysts have commented on KIDS shares. Piper Jaffray Companies started coverage on shares of Orthopediatrics in a research report on Monday, November 6th. They issued an “overweight” rating and a $24.00 price target on the stock. William Blair initiated coverage on shares of Orthopediatrics in a research report on Monday, November 6th. They set an “outperform” rating on the stock. Stifel Nicolaus initiated coverage on shares of Orthopediatrics in a research report on Monday, November 6th. They set a “buy” rating and a $23.00 target price on the stock. Finally, BTIG Research initiated coverage on shares of Orthopediatrics in a research report on Monday, November 6th. They set a “buy” rating and a $24.00 target price on the stock.

In related news, Director Harold Ruf bought 11,500 shares of Orthopediatrics stock in a transaction dated Monday, October 16th. The shares were bought at an average cost of $13.00 per share, for a total transaction of $149,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://www.com-unik.info/2017/12/22/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-orthopediatrics-kids-stock-price.html.

About Orthopediatrics

OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Insider Buying and Selling by Quarter for Orthopediatrics (NASDAQ:KIDS)

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit